Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference

Rhea-AI Summary

Biofrontera Inc. (Nasdaq: BFRI) will present at the LD Micro Main Event XV on October 26, 2022, at 4:00 PM Pacific Time at the Luxe Sunset Boulevard Hotel, Los Angeles, CA. CEO Erica Monaco will discuss the company’s dermatological products, focusing on photodynamic therapy and topical antibiotics for treating conditions like actinic keratoses and impetigo. A live webcast will be available at this link, and archived later on their website.

WOBURN, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that Erica Monaco, Chief Executive Officer, will be presenting and meeting with registered investors at the LD Micro Main Event XV that will be held October 25-27, 2022 at the Luxe Sunset Boulevard Hotel in Southern California.

Event:	LD Micro Main Event XV
Date:	Wednesday, October 26, 2022
Presentation Time:	4:00 PM Pacific Time (7:00 PM Eastern Time)
Location:	Luxe Sunset Boulevard Hotel, Los Angeles, CA
Webcast:	https://me22.sequireevents.com

A webcast of the presentation will be live and archived on the News & Events section of the company website. Institutional investors registered for the conference who would like to meet with Erica Monaco and Hermann Lübbert, Executive Chairman of Biofrontera Inc., please contact LD Micro directly or the BFRI investor relations team.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

# # #

FAQ

When is Biofrontera's presentation at the LD Micro Main Event XV?

Biofrontera's presentation is scheduled for October 26, 2022, at 4:00 PM Pacific Time.

Where is the LD Micro Main Event XV taking place?

The event is being held at the Luxe Sunset Boulevard Hotel in Los Angeles, California.

Who will represent Biofrontera at the LD Micro Main Event XV?

CEO Erica Monaco and Executive Chairman Hermann Lübbert will represent Biofrontera.

How can investors access the presentation by Biofrontera?

Investors can access the presentation via a live webcast at https://me22.sequireevents.com.

What is Biofrontera's focus in dermatology?

Biofrontera specializes in photodynamic therapy and topical antibiotics for treating skin conditions.

What are the key products offered by Biofrontera?

Biofrontera's products target dermatological conditions such as actinic keratoses and impetigo.